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Abstract
Background: Catch up growth (CUG) motivated by under-nutrition can lead to insulin resistance (IR) and visceral
fat over-accumulation. However, the precise mechanisms on IR induced by adipose tissue changes during CUG
remain unresolved.
Methods: Experimental rats were divided into three groups: normal chow group, catch up growth group and
resveratrol administrated group. The whole experiment was carried out in four stages: 4, 6, 8 and 12 weeks.
Peroxisome-proliferator activated receptor gamma (PPAR-γ) and fat-specific protein 27 (FSP27) expression level in
epididymal adipose tissues (EAT) and subcutaneous adipose tissues (SAT) were detected along with other IR indicators.
Results: Calorie restriction (CR) significantly increased PPAR-γ expression in EAT while decreased FSP27 expression.
During re-feeding, both of the expression of PPAR-γ and FSP27 increased, even FSP27 returned to normal level when
CUG for 4 weeks. Although PPAR-γ expression declined slightly at 8 weeks, it was still much stronger than normal
chow groups. However, no changes were seen in SAT. Relative insufficiency of FSP27 expression in EAT results in a
decrease in lipid storage capacity, causing a series of path physiological changes that led to the formation of IR.
Resveratrol inhibited the expression of PPAR-γ and promoted FSP27 expression, thus fundamentally improving IR.
Conclusions: The imbalance between adipose synthesis and storage mediated by PPAR-γ / FSP27 in the EAT plays a
pivotal role in the formation of IR during CUG. Resveratrol can correct fat formation and storage imbalance status by
up-regulating FSP27 and down-regulating PPAR-γ expression level, ameliorating insulin sensitivity.
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Background
Nutritional rehabilitation after malnutrition could motiv-
ate catch up growth, which has been characterized by
rapid growth after a temporary period of growth retard-
ation and apparent insulin resistance and an accelerated
rate of fat storage [1, 2]. Redistribution of glucose from
skeletal muscle to adipose tissue [3] and increased adipose
tissue lipid synthesis ability [4] enhance conversion of glu-
cose to lipids in fat stores, eventually leading to fat catch
up preferentially [4]. Adipose tissue is recognized as key
contributor to the systemic insulin resistance and overt
diabetes seen in metabolic syndrome [5]. However, lipid
synthesis enhancement alone does not necessarily cause
IR, as evidenced by good insulin sensitivity in a few obese
persons [6]. Moreover, the thiazolidinediones which are
selective ligands for the nuclear transcription factor per-
oxisome proliferator-activated receptor (PPAR) γ [7] can
improve IR partially by promoting the storage of triacyl-
glycerol in adipocytes, thus decreasing ectopic lipid depos-
ition and enhancing insulin sensitivity [8]. Therefore, the
formation of IR during CUG is not completely explained
merely by an improvement in lipogenesis and increased
fat content. Other pathways by which changes in adipose
tissue occur should be explored.
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Recent research has demonstrated that fat storage cap-
acity might represent a contributing factor in the varying
degrees of insulin resistance observed among obese hu-
man subjects, with an inverse correlation between fat
storage capacity and insulin resistance [6]. Efficient stor-
age of excess fatty acids within adipocyte lipid droplets
serves to protect other cells and tissues from their lipo-
toxic effects [9, 10] reducing the risk of IR occurrence.
Adipocytes express high levels of two distinct lipid drop-
let proteins, FSP27 (also called CIDEC), a member of
the CIDE family, and perilipin1 (PLIN1), a member of
the PAT family [11, 12]. The C-terminus domain, aa
120–220, of FSP27 interacts with PLIN1 to regulate lipid
droplet size in adipocytes [12], and PLIN1 acts as a scaf-
fold for FSP27 at the LD surface where FSP27 facilitates
the fusion of LDs [13]. Compared to PLIN1, studies have
confirmed that caloric restriction reduced the expression
of FSP27 [14], according to the experimental design and
intention, we explored changes in FSP27 during CUG.
As shown previously, lipogenesis key gene PPAR-γ is
markedly enhanced in the CUG process [4]. PPAR-γ,
which is a master regulator of adipogenesis [15, 16], be-
longs to the nuclear receptor super-family of ligand-
activated transcription factors and plays a pivotal part in
lipid biosynthesis [16]. Genes regulated by PPAR-γ are
diferentially regulated not only by agonist binding but also
by phosphorylation of the ligand binding domain of PPAR,
including Acyl, aP2, Plin1, C/EBPα and other genes, up to
dozens of species [17–20]. It has been suggested that loss
of PPAR-γ expression in murine embryonic fibroblasts
leads to a complete absence of adipogenic capacity [21].
As is known to all, nutrition deficiency is the main driving
factor of CUG, previous studies have suggested that CR
can increase adipose tissue expression of PPAR-γ [22, 23],
and also affects fat storage capacity. Magnusson et al.
found that CR could significantly reduce the FSP27expres-
sion [14]. We therefore postulate that the opposite
changes in PPAR-γ and FSP27 during CUG motivated by
CR may be the main reason of the formation of IR.
Resveratrol, a polyphenol found in red wine that is asso-
ciated with a surprising number of health benefits [24], can
ameliorate IR [25, 26]. Previous studies have demonstrated
that PPAR-γ is closely associated with IR [27]. Resveratrol
negatively modulates PPAR-γ protein levels [28] through
activating SIRT-1 deacetylase activity [29, 30]. However, to
our knowledge, no previous studies have addressed how
resveratrol influences FSP27 in adipose tissue. Therefore,
in this study, we investigated whether resveratrol can ef-
fectively correct the PPAR-γ/FSP27 ratio in CUG rats.
Briefly, the general objectives of this study were three
fold. The first was to explore the mechanism of IR in-
duced by adipose tissue, including changes in PPAR-γ/
FSP27 ratio and relevant indicators of IR during CUG
process. The second aim was to compare the effects of
resveratrol intervention on PPAR-γ/FSP27. Finally, we
assessed the role of expression imbalance between adi-
pose synthesis and storage mediated by PPAR-γ/FSP27
in the formation of IR in CUG model.
Methods
Animals and diets
Fifty-four healthy male Sprague–Dawley rats weighing
140–180 g were purchased at 6 weeks of age, (Center of
Experimental Animals, Tongji Medical College, Huazhong
University of Science and Technology, China, SCXK (E)
2010–0009) and acclimatized for 1 week. The animals were
individually housed in stainless steel cages with free access
to standard chow pellets and water, under uniform housing
in environmentally controlled conditions (22 ± 2 °C, 12-h
light–dark cycle, and 55–65 % humidity). The calorie of
normal chow contained 14 % fat, 64 % carbohydrate, and
22 % protein (per 100 g: 6.9 g fat, 69.3 g carbohydrate,
23.8 g protein), which was provided by the Laboratory
Animal Center of Tongji Medical College mentioned
above. All protocols of animal treatment were approved by
the institutional animal ethics committee.
Experimental design
The rats were randomly divided into three groups: nor-
mal chow group (NC group, containing NC4, NC8 and
NC12 subgroups); catch up growth group (CUG group,
containing three subgroups RN2, RN4 and RN8); catch
up growth with resveratrol administrated group (CUGE
group, containing R4E and RN8E subgroups). The whole
experiment was carried out in four stages: 4, 6, 8 and
12 weeks, and statistical analysis was conducted on the
related indexes of the experimental animals with the
same growth period (NC4, R4 and R4E; NC8 and RN4;
NC12, RN8 and RN8E) (Table 1). The animals in the
CUG and CUGE groups were restricted to 60 % of the
normal chow consumption of their counterparts in the
control groups for four weeks (R4) and then were re-fed
Table 1 Primer design for genes analyzed by real-time PCR
SYBR Green RT-PCR Primers Forward Primer Reverse primer Annealing temperature
PPAR-γ TGTCGGTTTCAGAAGTGCCTTG TTCAGCTGGTCGATATCACTGGAG 60 °C
FSP-27 AAGGCATCATGGCCCACAG TCTCCACGATTGTGCCATCTTC 58 °C
SIRT-1 TCCTCACTAATGGCTTTCATTCCTG GTGCCAATCATGAGATGTTGCTG 57 °C
β-Actin GGAGATTACTGCCCTGGCTCCTA GACTCATCGTACTCCTGCTTGCTG 62 °C
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for 2, 4 or 8 weeks. During this time, food intake was
strictly matched with that of pair-fed controls, to avoid
the hyperphagic response (RN versus NC). To study adi-
pose synthesis and storage changes in the whole experi-
mental process, we detected related parameters at the
end of the caloric restriction (R4) groups. Resveratrol
(Sigma, St Louis, MO) mixed with saline solution (0.9 %
normal saline, NS) was administered orally by gavage in
R4E (4-week CR plus resveratrol intervention) and
RN8E groups (the same dietary pattern as with RN8 plus
resveratrol treatment, that is, resveratrol intervention
after 4-week CR) (100 mg/kg/d). The other groups re-
ceived a corresponding volume of saline solution every
day. Taken together, this study contained nine subgroups,
and each subgroup contained six animals (Table 1).
Body weight and body fat measurement by DEXA
Body weight in experimental 4 and 12 weeks subgroups
(including NC4,
R4, R4E, NC12, RN8, RN8E groups) was measured
every day. Whole-body composition was measured by
dual-energy X-ray absorptiometry (DEXA) with a scan-
ner (Lunar prodigy advanced, GE Company) by the same
experienced technician. At the end of 4 and 12 experi-
mental weeks (Fig. 1), rats were first anesthetized by in-
traperitoneal injection of pentobarbital (30 mg/kg body
weight) and were then were placed in supine position,
both upper and lower extremities extended, and fixed to
the examining table (Fig. 2, which was collected in the
automatic imaging of the machine). Fat content of torso
tissue and whole body tissue, and the ratio of torso fat
to whole body fat were determined.
Hyperinsulinemic–euglycemic clamp in conscious status
and measurement of in vivo 2-deoxy-D-glucose (2-DG)
uptake in adipose tissue
A 120-min hyperinsulinemic–euglycemic clamp in con-
scious rats based on tail artery measurement of 2-DG
(Sigma-Aldrich, St Louis, MO) uptake in adipose tissue
was determined as described previously [1]. Blood samples
(20 μl) were collected every five minutes for plasma
glucose determination using a glucometer (One Touch
Ultra, Lifescan, Milpitas, CA, USA). The average glucose in-
fusion rate between the 60th and 120th minute (GIR60–120)
was used to evaluate systemic insulin sensitivity.
Hematoxylin and eosin (H & E) staining
Fresh tissues (epididymal adipose tissues) were collected
and fixed in 4%neutral buffered formalin solution (HT50-
Fig. 1 The experimental design, each subgroup included 6 rats
Fig. 2 Photograph of body fat measurement by DEXA
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1-2; Sigma). The tissues were then embedded in paraffin,
cut into 4 μm thick sections, mounted on glass slides, and
stained with hematoxylin and eosin solution (H & E), and
processed according to standard procedure.
Adipose tissue SIRT1 Activity determination
Enzyme activity assay of SIRT1 was carried out using
a commercial kit (Genmed Scientifics) as described
before [25].
RNA extraction and real-time RT-PCR
Total RNA was extracted from the epididymal and sub-
cutaneous adipose tissue using Trizol reagent (RNAiso™
Plus, TaKaRa Code D9108B, Japan) according to the man-
ufacturer’s protocol. The quantity and quality of the total
RNA was verified with a spectrophotometer. The process
of synthesizing single-stranded complementary DNA and
target gene amplification was carried out as previously re-
ported [25]. Real time PCR reactions were conducted in
an ABI 7900 HT apparatus (Applied Biosystems) in tripli-
cate. Specific kits used were as follows: 2-step RT-PCR:
Prime Script ® RT Master Mix Perfect Real Time, TaKaRa
Code DRR036S, Japan; Real-Time PCR System: SYBR
Green I dye (TaKaRa Code DRR420A, Japan). Relative ex-
pression levels were calculated using the comparative Ct
(2−ΔΔCt) method with β-actin RNA as the endogenous
control. Oligonucleotide sequences of forward and reverse
primers are shown in Table 1.
Western blot analysis
Western blot analysis was performed to determine target
protein expression including adipose formation and stor-
age proteins (PPAR-γ, FSP27). Total proteins were ex-
tracted from adipose tissue samples using a Total Protein
Extraction kit (Beyotime, Shanghai, China) according to
the manufacturer’s instructions. Took adipose tissue sam-
ples, weighed, according to the proportion of weight: vol-
ume = 1:6 to add protein lysis solution, full grinding. Total
protein concentration was calculated by BCA protein re-
agent (Pierce, Rockford, IL, USA), and the concentration
was not less than 2 μg/μl. Then, 60 μg of protein lysate
per sample was determined. Proteins were then separated
by sodium dodecyl sulfate polyacryl-amide gel electro-
phoresis and transferred to PVDF membrane.
The membrane was incubated with appropriate poly-
clonal primary antibodies (Cell Signaling Technology,
USA) (PPAR-γ and FSP27 antibody, 1:3000 and 1: 1500 di-
luted in 5 % non-fat milk, respectively). All Western blots
shown were representative of at least two independent ex-
periments and quantified by densitometry analysis.
Blood sample detection
Plasma adiponectin, TNF-α concentrations and basal in-
sulin were measured with enzyme-linked immunosorbent
assays with commercial kits (Westang Biotechnology,
Shanghai, China; Linco RIA rat insulin kit, St Charles,
MO). Serum free fatty acid (FFA) and triglyceride (TG)
levels were performed by a colorimetric enzymatic
method (Wako nonesterified fatty acid C kit, Richmond,
VA, and GPO-PAP, Roche Diagnostics, Indianapolis, IN).
Statistical analysis
All analyses were performed with the Statistical Package
for Social Sciences version 16.0 (SPSS, Chicago, IL). Re-
sults were presented as the mean ± SD. Differences in
bone parameters among groups were investigated using
one-way analysis of variance (ANOVA). Statistical sig-
nificance level was considered at P < 0.05.
Results
Body weight and body fat distribution
During the four-week diet restriction period, body
weight of rats decreased significantly compared with the
NC4 group. After re-feeding for 8 weeks, it was still con-
sistently lower than the normal level (P < 0.05, RN8 vs.
NC12) (Fig. 3a). Food restriction induced a slight in-
crease in fat content of torso tissue and whole body tis-
sue, and in the ratio of torso fat/whole body fat in R4
group, but the values did not reach statistical signifi-
cance compared to NC4 group (Fig. 3b-d). Following the
8-week catch up growth, fat content of torso and whole
body tissue significantly increased, meanwhile torso fat/
whole body fat ratio also distinctly increased compared
with NC12 group (P < 0.01) (Fig. 3b-d). However, in res-
veratrol intervention groups, body weight and body fat
content was significantly lower than the control groups
(R4E vs. R4, RN8E vs. RN8), and body fat content in the
RN8E group was virtually reduced to or far below nor-
mal level in the R4E group (Fig. 3a-d).
Systemic and adipose tissue insulin sensitivity
Fasting blood glucose (FBG) and fasting insulin (FINS)
levels did not change significantly in R4 groups (P > 0.05,
R4 vs. NC4). CUG led to a non-significant increase in
FBG levels (P > 0.05, RN8 vs. NC12). FINS levels were
notably increased in RN8 group (P < 0.01, RN8 vs. NC12)
(Fig. 4a, b). Food restriction induced a slight increase in
the average GIR60–120 at hyperinsulinemic-euglycemic
clamp, but it was not statistically significant compared
with the normal group. However, the average GIR60–120
decreased significantly in the RN8 group (P < 0.05, RN8
vs. NC12) (Fig. 4c). Distinctly increased FINS levels and
decreased GIR60–120 induced by CUG indicated systemic
IR. In addition, insulin-stimulated glucose uptake in
epididymal adipose tissue was increased by diet restriction
(∼15 %, R4 vs. NC4, P <0.01), and this increase was further
enhanced in CUG (∼29 %, P < 0.01, RN8 vs. NC12) (Fig. 4d).
However, although glucose uptake in subcutaneous tissue
Wang et al. Lipids in Health and Disease  (2016) 15:173 Page 4 of 12
was also increased during diet restriction and CUG,
the changes were less remarkable compared to those
seen in epididymal adipose tissue (Fig. 4e). Resveratrol
treatment decreased FINS levels, and increased GIR60–120
and adipose tissues glucose uptake as shown in CUG
group (P <0.01, RN8E vs. RN8) (Fig. 4b-e). However,
only adipose tissue glucose uptake was increased in
R4E group. FINS levels and GIR60–120 were not altered
(Fig. 4a-e). We also found that resveratrol had little effect
on FBG (Fig. 4a).
The morphology of epididymal adipocyte
In investigating the cell size of the epididymal adipose,
we found that the diameter of adipose cells in the R4
group was smaller than in the control group (P < 0.01,
R4 vs. NC4) (Fig. 5a, b); while in the RN8 group adipose
cell’ diameter was obviously larger, with abnormal shape,
appearing fused with each other (P < 0.01, RN8 vs.
NC12) (Fig. 5d, e). Resveratrol decreased the size of
adipocytes observed in R4E and RN8E groups and
protected the integrity of cell membranes (P <0.01,
RN8E vs. RN8, R4E vs. R4) (Fig. 5c, f ).
Alteration of SIRT1 activity and mRNA analysis in adipose
tissue
The R4 rats showed more than a 30 % increase (P < 0.01)
in epididymal and subcutaneous adipose SIRT1 activity,
but a significant reduction was observed in the RN8 group
compared with the control rats (31 % ∼ 35 %, P < 0.01)
(Fig. 6a, b). Conversely, oral administration of resveratrol
distinctly improved SIRT1 activity, which either matched
or exceeded NC group when the 8-week re-feeding ended
(Fig. 6a, b). SIRT1 real-time RT-PCR analysis was consist-
ent with the activity results real-time RT-PCR analysis was
consistent with the activity results (Fig. 7e).
Inconsistent expression levels of PPAR-γ and FSP27 in CUG
To investigate the changes of adipose formation and
storage capacity during CUG, we analyzed PPAR-γ and
FSP27 mRNA and protein expression levels. Western
Fig. 3 Comparisons of body weight (a) and fat content (b, c, d) Pre- and Post- resveratrol treatment. Food restriction induced a significant
decrease in body weight, after re-feeding for 8 weeks, it was still consistently lower than the normal level, but fat content of torso and whole
body tissue significantly increased. After resveratrol intervention, body weight and body fat content was significantly lower than the control
groups. † P < 0.05 versus NC4 group, § P < 0.01 versus NC4 group. △P < 0.05 versus R4 group, ▲P < 0.01 versus R4 group. *P < 0.05 versus
NC12 group, #P < 0.01 versus NC12 group. ☆P < 0.05 versus RN8 group, ★P < 0.01 versus RN8 group
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blot analysis of epididymal adipose tissue suggest that
diet restriction increased PPAR-γ expression but sup-
pressed FSP27 expression compared with normal group
(Fig. 8a). After re-feeding, PPAR-γ expression levels in-
creased significantly, and achieved the highest level at
CUG of 4 weeks. Although it decreased to some degree
at the end of the experiment, it was still far higher than
the NC12 group (Fig. 8a). These results were consistent
with FSP27 and PPAR-γ mRNA expression (Fig. 7a).
Relative to PPAR-γ, low level protein expression of
FSP27 induced by diet restriction gradually increased
and virtually recovered to normal levels after re-feeding
for 4 weeks, then exceeded the NC group when the ex-
periment ended (Fig. 8a). However, the alteration of
PPAR-γ expression levels was not obvious during the
CUG process in subcutaneous adipose tissue (Figs. 7b
and 8b), and, thus, we did not detect FSP27 expression
levels in this tissue. Both PCR and western blot analysis
indicated that resveratrol treatment markedly reduced epi-
didymal adipose tissue PPAR-γ expression (Figs. 7c and 8c),
Fig. 5 HE staining of epididymal adipocytes in each group (400×). Food restriction made epididymal adipocytes significantly smaller, after CUG
adipose cell’ diameter was obviously larger, with abnormal shape. Resveratrol decreased the size of adipocytes and protected the integrity of cell
membranes. §P < 0.01 versus NC4 group,▲P < 0.01 versus R4 group. ★P < 0.01 versus RN8 group
Fig. 4 FBG (a), FINS (b), GIR60–120 levels (c), and 2-DG uptake (d, e) Pre- and Post- resveratrol treatment. Hyperinsulinemic-euglycemic clamp
showed that fasting blood glucose, fasting insulin and GIR60–120levels did not change significantly in R4 groups, CUG led to a significant
increase in FINS levels and decrease GIR60–120 in epididymal adipose tissue. Resveratrol treatment decreased FINS levels, increased GIR60–120
and adipose tissues glucose uptake as shown in CUG group. §P < 0.01 versus NC4 group, △P < 0.05 versus R4 group. ▲P < 0.01 versus
R4 group, *P < 0.05 versus NC12 group. #P < 0.01 versus NC12 group,☆P < 0.05 versus RN8 group. ★P < 0.01 versus RN8 group
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but up-regulated FSP27 expression levels (Figs. 7d and 8d).
SIRT1 expression levels also were up-regulated in epididy-
mal adipose tissue (Fig. 7e).
Serum FFA /TG and Plasma TNF-α/ adiponectin
concentrations
Compared with the control, blood lipid FFA (Fig. 9c)
was increased and TG (Fig. 9d) was lower in the diet re-
striction stage, but both of them were significantly ele-
vated in RN8 group. The levels of TNF-α did not change
significantly during the diet restriction period compared
to NC group, while they were markedly increased in the
RN8 group (Fig. 9a). However, adiponectin levels, which
changed inversely with TNF-α, increased because of diet
restriction but decreased significantly during CUG
(Fig. 9b). Resveratrol treatment had no major impact on
blood lipid levels (Fig. 9c, d), but decreased TNF-α levels
and increased adiponectin levels in the experimental rats
(Fig. 9a, b).
Discussion
Adipose tissue is an important metabolic organ that is
crucial for whole-body insulin sensitivity and energy
homeostasis, and IR states. Compared to other parts adi-
pose tissue of the body, visceral adipose tissue plays an
important role in IR [31]. Lipids synthesis and storage
are affected by many factors, among them, the nuclear
hormone receptor PPAR-γ is a central regulator of adi-
pogenesis and plays a dominant role in fat tissue devel-
opment [15, 16]. FSP27/Cidec is most highly expressed
in white and brown adipose tissues and increases in
abundance by over 50-fold during adipogenesis [32]. De-
pletion of FSP27 by siRNA in murine -cultured white
adipocytes resulted in the formation of numerous small
lipid droplets and the almost total disappearance of large
lipid droplets [33]. PPAR-γ and FSP27 play an important
role in lipid synthesis and storage, so we think they can
be used to assess the ability of lipid synthesis and storage
to a certain extent.
In our study, 4-week diet restriction made the body
weight of rats decrease significantly compared with the
NC4 group. And, calorie restriction obviously increased
PPAR-γ expression but suppressed FSP27 expression in
epididymal adipose tissues compared with the normal
group. It could be suggested that weight loss caused cel-
lular stress in adipocytes and improved adipogenesis
[34], while PPAR-γ was a central regulator of adipogene-
sis [15, 16], so we speculate that the weight loss caused
by diet restriction stimulates lipid synthesis, and then in-
creases PPAR-γ expression. Similarly, other studies also
observed that calorie restriction significantly increased
the expression of PPAR-γ [22, 23]. There is less research
on the relationship between calorie restriction and
FSP27. Our data indicated that calorie restriction obvi-
ously suppressed FSP27 expression in epididymal adipose
tissues. Similar observations had been made by Magnus-
son [14]. We speculate that it is the decrease in caloric in-
take per se that leads to reduced FSP27 expression.
Whether there are other genes involved in the regulation
is not clear, and needs further study. In addition, the ex-
pression of PPAR-γ and FSP27 did not return to normal
level after 8-week catch up growth, which was possibly re-
lated to the short observation time. This study showed
that calorie restriction led the expression of PPAR-γ and
FSP27 to appearing the opposite trend. However, recent
studies demonstrate that FSP27 gene is a direct down-
stream target of PPAR-γ and specifically regulated by
PPAR-γ [35]. This seemingly contradictory change be-
tween the two genes caused by calorie restriction can be
explained by the fact that nutrition substrate may play a
major role during this process, because the expression of
many adipocyte-specific genes is affected by dietary ma-
nipulations [36]. Due to inadequate nutrient substrate
supply, down-regulation of FSP27 might be part of an
adaptation by the adipocyte to whole-body energy defi-
ciency [23], resulting in reduced lipid storage. In our
study, although the capability of adipogenesis mediated by
PPAR-γ increased due to calorie restriction, it only
showed a potential and could not be exerted because of
Fig. 6 Alteration SIRT1 activity in epididymal (a) and subcutaneous (b) adipose tissue. The R4 rats showed a significant increase in SIRT1 activity in
adipose tissue, but an obvious reduction in the RN8 group. Oral administration of resveratrol distinctly improved SIRT1 activity. §P< 0.01 versus NC4 group,
▲P< 0.01 versus R4 group. #P< 0.01 versus NC12 group,☆P< 0.05 versus RN8 group,★P< 0.01 versus RN8 group
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energy deficiency. Once the supply of nutrients was ad-
equate as was the case during re-feeding, both PPAR-γ
and FSP27 showed the same tendency, and increased to
different degrees. Although fat storage capability (FSP27)
was gradually enhanced and even exceeded NC at the end
of the experiment, it was still relatively deficient compared
to the continued up-regulation of fat synthesis capability
(PPAR-γ). Based on the above observations, we reason
that the inconsistent changes of lipid generation and stor-
age caused by under-nutrition are the primary reason for
IR formation during CUG.
Similar to the previous studies [1, 3], our CUG models
showed the accelerated rate of fat recovery. Although
body weight in RN8 group was still lower than the nor-
mal levels, DEXA results indicated that fat content of
torso and torso fat/ whole body fat ratio in RN8 dis-
tinctly improved compared with NC group. We specu-
lated that insulin-stimulated increase of glucose uptake
in adipose tissue of RN8 group enhanced the availability
of raw materials for fat synthesis. Additionally, FSP27
expression increased compared to NC at the end of re-
feeding for 8 weeks despite it still being relatively lower
than PPAR-γ, and the improved lipid storage capacity
promoted the fat accumulation. Eventually, all of these
changes led to the catch up of fat. Nevertheless, it is to
be noted that food-restricted rats had a slight increase in
fat content of torso tissue and whole body tissue in this
study. We speculated that brief calorie restriction
(4 weeks) increased PPAR-γ expression, while PPAR-γ
could promote the uptake of FFAs and increased the
content of TAGs in the adipocytes [37], and thereby im-
proved the body fat content [37]. Epidemiological as well
as other evidence indicate that abdominal fat is more
directly related to negative health outcomes than that of
subcutaneous fat [38]. In this study, we also noted that
although CR enhanced PPAR-γ expression of SAT, the
following CUG had little effect on it, which did not war-
rant further detection of FSP27 expression. In addition,
the glucose uptake of SAT did not change significantly
during CUG process compared with NC group. There-
fore, our study showed that CUG had little effect on
lipid synthesis of SAT, which further proved that the
changes of EAT during CUG played an important role
in the formation of IR. Regardless, this study is the first
to observe PPAR-γ expression and glucose uptake of
SAT in CUG rats. As noted above, this study reveals
new insights on CUG and IR, demonstrating that the
imbalance of adipose synthesis and storage mediated by
PPAR-γ/FSP27 in EAT play a pivotal role.
It is well known that the hyperinsulinemic-euglycemic
clamp is the criterion standard method with a high de-
gree of accuracy to assess insulin sensitivity. In this
study, the evidence of decreased steady-state GIR during
the clamp in the RN8 group and significantly increased
fasting insulin levels with normal fasting glucose con-
centration confirmed the presence of systemic IR. In
addition, we found that serum FFA and TG levels were
markedly elevated in the RN8 group compared with the
Fig. 7 Comparisons of the expression data (2Ct-values) in adipose tissue. The expression of PPAR-γ mRNA did not change significantly in
subcutaneous adipose (b), food restriction made PPAR and FSP27 mRNA expression change in different side, after catch up growth the
two mRNA expression were significantly higher than normal group. Resveratrol obviously inhibited PPAR mRNA expression, but increased FSP27
expression (a, c, and d); SIRT1 mRNA expression in epididymal adipose tissue was consistent with the activity results (E). §P < 0.01 versus NC4 group,
▲P < 0.01 versus R4 group, #P < 0.01 versus NC12group, ★P < 0.01 versus RN8 group, △P < 0.05 versus R4 group
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NC group. Elevated levels of lipids such as FFAs and tri-
glycerides are a key reason for the incidence of IR [39].
Adipocytokines are cytokines secreted by visceral adipo-
cytes, and they are associated with metabolic syndrome
and IR [40]. In our study, the levels of TNF-α increased
significantly in the RN8 group compared with the NC
group, However, adiponectin changed inversely with
TNF-α. TNF-α is a major mediator of chronic inflamma-
tion and insulin resistance [41], and neutralization of
TNF–α significantly improves insulin sensitivity [42].
Adiponectin has been related to enhanced insulin sensi-
tivity and anti-inflammatory effect with its plasma levels
Fig. 8 Comparisons of the PPAR-γ and FSP27 protein expression Pre-(a, b) and Post-(c, d) resveratrol intervention. PPAR-γ and FSP27 protein
expression levels and the effect of resveratrol intervention in epididymal adipose tissue were consistent with mRNA changes (Fig. 7a, c, d).
*P < 0.05 versus NC12 group, #P < 0.01 versus NC12group, †P < 0.05 versus RN8 group,▲P < 0.01 versus RN8 group. △P < 0.01 versus R4 group
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negatively correlated with visceral adiposity [43]. In this
study, the relative deficiency of fat storage capability
could not fully store the excessive lipid that was synthe-
sized, resulting in lipid spillover and abnormal adipokine
secretion, which led to the formation of IR.
Resveratrol is a natural polyphenol produced by plants
in response to environmental stress [44]. The data pre-
sented here indicated that resveratrol administration
markedly restrained PPAR-γ expression and up-regulated
FSP27 expression levels in EAT. The inhibitory role of res-
veratrol on PPAR-γ may be due to SIRT1 activation, since
resveratrol is a classic SIRT-1 activator [29, 30], and SIRT1
can repress PPAR-γ in white adipose tissue by docking
with its cofactor nuclear receptor co-repressor (NCoR)
[30]. In our study, we observed that SIRT1 activity and
mRNA expression were significantly reduced in RN8
group but distinctly improved after resveratrol administra-
tion. These results are also consistent with the changes
observed with PPAR-γ. Nevertheless, the effect of resvera-
trol on the expression of FSP27 has not been previously
reported, and only one study showed that resveratrol did
not modify perilipin expression, which is another common
lipid droplet-associated protein [45]. Sawada et al. found
that, a competition existed in vitro between FSP27 and
perilipin expression because both proteins preferentially
locate to lipid droplets [46]. Therefore, we speculate that
because of resveratrol up-regulation of FSP27 expression,
perilipin expression promotion was not favored, which led
to the observed result. The enhanced storage of triglycer-
ide in lipid droplets of adipose tissues decreases the fatty
acid levels in the circulation, thereby protecting muscle
and liver from high fatty acid levels, which improves insu-
lin sensitivity.
As noted above, adipose synthesis was in parallel with
storage during CUG with resveratrol intervention, and
systemic IR was improved as shown by decreased FINS
levels and increased steady-state GIR in RN8E group. Al-
though numerous studies on diabetic rats revealed the
anti-hyperglycemic action of resveratrol [25], this effect
was not obvious in our study. We observed that in resver-
atrol groups FBG was still comparable to those of the
non-treatment groups in addition to a slight decrease. It
was remarkable that body fat content and blood lipids
(serum FFA and TG) in RN8E group were significantly de-
creased. Possible explanations include inhibited PPAR-γ
inhibition by resveratrol through SIRT1activation [24],
Fig. 9 Comparisons of blood sample during CUG and with resveratrol intervention. Adiponectin and TNF-α levels changed inversely during CUG
(a, b), FFA and TG levels were significantly elevated in RN8 group (c, d). Resveratrol treatment had no major impact on blood lipid levels (c, d), but
decreased TNF-α levels and increased adiponectin levels (a, b). † P < 0.05 versus NC4 group, §P < 0.01 versus NC4 group. △P < 0.05 versus
R4 group, #P < 0.01 versus NC12group. ☆P < 0.05 versus RN8 group, ★P < 0.01 versus RN8 group
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and increased lipolysis and reduced lipogenesis in mature
adipocytes [47]. We further demonstrated that because of
the relative balance of fat synthesis and storage by resvera-
trol treatment, plasma adiponectin was markedly in-
creased and inflammation factor TNF-α decreased.
Mature adipocytes store triglycerides in a single fat
droplet that almost entirely fills the cell [48]. Therefore,
we thought the size of adipocytes would reflect the uni-
locular lipid droplet-size. Therefore, we studied the cell
size. Results showed that adipocyte diameter in EAT was
smaller during CR compared with the NC group. These
small adipocytes had a high potential to store lipids, and
could have improved insulin sensitivity [49]. However,
during CUG, adipocytes enlarge and their shape become
irregular, with incomplete cell membranes. These changes
led to cell membrane rupture, lipid overflow, and serum
FFA increase, and, eventually, IR. Resveratrol activated
SIRT1 which then repressed PPAR-γ transactivation and
inhibited lipid synthesis in adipocytes [30], at the same
time enhancing lipid storage capacity. These cells had a
high potential to store lipids, and, therefore, alleviate per-
ipheral lipotoxicity. Finally, the balance between lipid syn-
thesis and storage was restored so that fat cells were able
to store excess lipid, with adipocytes’ shape and membrane
almost returning to normal.
Conclusion
In conclusion, this study has shown that CR has opposing
effects on PPAR-γ and FSP27 of EAT, which becomes the
main reason for the imbalance between adipose tissue
synthesis and storage capacity. However, during the CUG
process that followed, both of them were enhanced to
varying degrees. The excessive lipid could not be stored
properly, resulting in lipid spillover and causing IR. The
imbalance between adipose synthesis and storage medi-
ated by PPAR-γ/FSP27 may serve as a new molecular tar-
get for the treatment of IR and related diseases. Similar to
CR, resveratrol induced upregulation of FSP27 and down-
regulation of PPAR-γ leading to the restoration of the bal-
ance between lipid production and storage. This provides
a potential treatment for IR.
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